Lung transplantation for cystic fibrosis

Frederick R. Adler, Paul Aurora, David H. Barker, Mark L. Barr, Laura S. Blackwell, Otto H. Bosma, Samuel Brown, D. R. Cox, Judy L. Jensen, Geoffrey Kurland, George D. Nossent, Alexandra Quittner, Walter M. Robinson, Sandy L. Romero, Helen Spencer, Stuart C. Sweet, Wim Van Der Bij, J. Vermeulen, Erik A M Verschuuren, Elianne J L E VrijlandtWilliam Walsh, Marlyn S. Woo, Theodore G. Liou

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Lung transplantation is a complex, high-risk, potentially life-saving therapy for the end-stage lung disease of cystic fibrosis (CF). The decision to pursue transplantation involves comparing the likelihood of survival with and without transplantation as well as assessing the effect of wait-listing and transplantation on the patient's quality of life. Although recent population-based analyses of the US lung allocation system for the CF population have raised controversies about the survival benefits of transplantation, studies from the United Kingdom and Canada have suggested a definite survival advantage for those receiving transplants. In response to these and other controversies, leaders in transplantation and CF met together in Lansdowne, Virginia, to consider the state of the art in lung transplantation for CF in an international context, focusing on advances in surgical technique, measurement of outcomes, use of prognostic criteria, variations in local control over listing, and prioritization among the United States, Canada, the United Kingdom, and The Netherlands, patient adherence before and after transplantation and other issues in the broader context of lung transplantation. Finally, the conference members carefully considered how efforts to improve outcomes for lung transplantation for CF lung disease might best be studied. This Roundtable seeks to communicate the substance of our discussions.

Original languageEnglish
JournalProceedings of the American Thoracic Society
Volume6
Issue number8
DOIs
StatePublished - Dec 15 2009

Fingerprint

Lung Transplantation
Cystic Fibrosis
Transplantation
Lung Diseases
Canada
Survival
Patient Compliance
Netherlands
Population
Quality of Life
Transplants
Lung

Keywords

  • Adherence
  • Lung transplantation
  • Quality of life
  • Study design
  • Survival

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Adler, F. R., Aurora, P., Barker, D. H., Barr, M. L., Blackwell, L. S., Bosma, O. H., ... Liou, T. G. (2009). Lung transplantation for cystic fibrosis. Proceedings of the American Thoracic Society, 6(8). https://doi.org/10.1513/pats.2009008-088TL

Lung transplantation for cystic fibrosis. / Adler, Frederick R.; Aurora, Paul; Barker, David H.; Barr, Mark L.; Blackwell, Laura S.; Bosma, Otto H.; Brown, Samuel; Cox, D. R.; Jensen, Judy L.; Kurland, Geoffrey; Nossent, George D.; Quittner, Alexandra; Robinson, Walter M.; Romero, Sandy L.; Spencer, Helen; Sweet, Stuart C.; Van Der Bij, Wim; Vermeulen, J.; Verschuuren, Erik A M; Vrijlandt, Elianne J L E; Walsh, William; Woo, Marlyn S.; Liou, Theodore G.

In: Proceedings of the American Thoracic Society, Vol. 6, No. 8, 15.12.2009.

Research output: Contribution to journalArticle

Adler, FR, Aurora, P, Barker, DH, Barr, ML, Blackwell, LS, Bosma, OH, Brown, S, Cox, DR, Jensen, JL, Kurland, G, Nossent, GD, Quittner, A, Robinson, WM, Romero, SL, Spencer, H, Sweet, SC, Van Der Bij, W, Vermeulen, J, Verschuuren, EAM, Vrijlandt, EJLE, Walsh, W, Woo, MS & Liou, TG 2009, 'Lung transplantation for cystic fibrosis', Proceedings of the American Thoracic Society, vol. 6, no. 8. https://doi.org/10.1513/pats.2009008-088TL
Adler FR, Aurora P, Barker DH, Barr ML, Blackwell LS, Bosma OH et al. Lung transplantation for cystic fibrosis. Proceedings of the American Thoracic Society. 2009 Dec 15;6(8). https://doi.org/10.1513/pats.2009008-088TL
Adler, Frederick R. ; Aurora, Paul ; Barker, David H. ; Barr, Mark L. ; Blackwell, Laura S. ; Bosma, Otto H. ; Brown, Samuel ; Cox, D. R. ; Jensen, Judy L. ; Kurland, Geoffrey ; Nossent, George D. ; Quittner, Alexandra ; Robinson, Walter M. ; Romero, Sandy L. ; Spencer, Helen ; Sweet, Stuart C. ; Van Der Bij, Wim ; Vermeulen, J. ; Verschuuren, Erik A M ; Vrijlandt, Elianne J L E ; Walsh, William ; Woo, Marlyn S. ; Liou, Theodore G. / Lung transplantation for cystic fibrosis. In: Proceedings of the American Thoracic Society. 2009 ; Vol. 6, No. 8.
@article{905884c6c26641a2afa9e6cdccfb30c9,
title = "Lung transplantation for cystic fibrosis",
abstract = "Lung transplantation is a complex, high-risk, potentially life-saving therapy for the end-stage lung disease of cystic fibrosis (CF). The decision to pursue transplantation involves comparing the likelihood of survival with and without transplantation as well as assessing the effect of wait-listing and transplantation on the patient's quality of life. Although recent population-based analyses of the US lung allocation system for the CF population have raised controversies about the survival benefits of transplantation, studies from the United Kingdom and Canada have suggested a definite survival advantage for those receiving transplants. In response to these and other controversies, leaders in transplantation and CF met together in Lansdowne, Virginia, to consider the state of the art in lung transplantation for CF in an international context, focusing on advances in surgical technique, measurement of outcomes, use of prognostic criteria, variations in local control over listing, and prioritization among the United States, Canada, the United Kingdom, and The Netherlands, patient adherence before and after transplantation and other issues in the broader context of lung transplantation. Finally, the conference members carefully considered how efforts to improve outcomes for lung transplantation for CF lung disease might best be studied. This Roundtable seeks to communicate the substance of our discussions.",
keywords = "Adherence, Lung transplantation, Quality of life, Study design, Survival",
author = "Adler, {Frederick R.} and Paul Aurora and Barker, {David H.} and Barr, {Mark L.} and Blackwell, {Laura S.} and Bosma, {Otto H.} and Samuel Brown and Cox, {D. R.} and Jensen, {Judy L.} and Geoffrey Kurland and Nossent, {George D.} and Alexandra Quittner and Robinson, {Walter M.} and Romero, {Sandy L.} and Helen Spencer and Sweet, {Stuart C.} and {Van Der Bij}, Wim and J. Vermeulen and Verschuuren, {Erik A M} and Vrijlandt, {Elianne J L E} and William Walsh and Woo, {Marlyn S.} and Liou, {Theodore G.}",
year = "2009",
month = "12",
day = "15",
doi = "10.1513/pats.2009008-088TL",
language = "English",
volume = "6",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "8",

}

TY - JOUR

T1 - Lung transplantation for cystic fibrosis

AU - Adler, Frederick R.

AU - Aurora, Paul

AU - Barker, David H.

AU - Barr, Mark L.

AU - Blackwell, Laura S.

AU - Bosma, Otto H.

AU - Brown, Samuel

AU - Cox, D. R.

AU - Jensen, Judy L.

AU - Kurland, Geoffrey

AU - Nossent, George D.

AU - Quittner, Alexandra

AU - Robinson, Walter M.

AU - Romero, Sandy L.

AU - Spencer, Helen

AU - Sweet, Stuart C.

AU - Van Der Bij, Wim

AU - Vermeulen, J.

AU - Verschuuren, Erik A M

AU - Vrijlandt, Elianne J L E

AU - Walsh, William

AU - Woo, Marlyn S.

AU - Liou, Theodore G.

PY - 2009/12/15

Y1 - 2009/12/15

N2 - Lung transplantation is a complex, high-risk, potentially life-saving therapy for the end-stage lung disease of cystic fibrosis (CF). The decision to pursue transplantation involves comparing the likelihood of survival with and without transplantation as well as assessing the effect of wait-listing and transplantation on the patient's quality of life. Although recent population-based analyses of the US lung allocation system for the CF population have raised controversies about the survival benefits of transplantation, studies from the United Kingdom and Canada have suggested a definite survival advantage for those receiving transplants. In response to these and other controversies, leaders in transplantation and CF met together in Lansdowne, Virginia, to consider the state of the art in lung transplantation for CF in an international context, focusing on advances in surgical technique, measurement of outcomes, use of prognostic criteria, variations in local control over listing, and prioritization among the United States, Canada, the United Kingdom, and The Netherlands, patient adherence before and after transplantation and other issues in the broader context of lung transplantation. Finally, the conference members carefully considered how efforts to improve outcomes for lung transplantation for CF lung disease might best be studied. This Roundtable seeks to communicate the substance of our discussions.

AB - Lung transplantation is a complex, high-risk, potentially life-saving therapy for the end-stage lung disease of cystic fibrosis (CF). The decision to pursue transplantation involves comparing the likelihood of survival with and without transplantation as well as assessing the effect of wait-listing and transplantation on the patient's quality of life. Although recent population-based analyses of the US lung allocation system for the CF population have raised controversies about the survival benefits of transplantation, studies from the United Kingdom and Canada have suggested a definite survival advantage for those receiving transplants. In response to these and other controversies, leaders in transplantation and CF met together in Lansdowne, Virginia, to consider the state of the art in lung transplantation for CF in an international context, focusing on advances in surgical technique, measurement of outcomes, use of prognostic criteria, variations in local control over listing, and prioritization among the United States, Canada, the United Kingdom, and The Netherlands, patient adherence before and after transplantation and other issues in the broader context of lung transplantation. Finally, the conference members carefully considered how efforts to improve outcomes for lung transplantation for CF lung disease might best be studied. This Roundtable seeks to communicate the substance of our discussions.

KW - Adherence

KW - Lung transplantation

KW - Quality of life

KW - Study design

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=74849109088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849109088&partnerID=8YFLogxK

U2 - 10.1513/pats.2009008-088TL

DO - 10.1513/pats.2009008-088TL

M3 - Article

AN - SCOPUS:74849109088

VL - 6

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 8

ER -